It was only 3% of his holding (honestly not even worth the mention and forgettable yet you brought it up lol) and he could have held and sold at a higher price. Also, the pps did recover after the excellent clinical trial update for Azer-Cel but this was 10 months after VAXINIA. If the pps doesn't sustain the re-rate after continue further positive clinical trial updates expected this year then you can start blaming him.......
Ann: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings, page-184
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $100.8M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $169.0K | 12.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 80 | 17208520 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 7560901 | 19 |
View Market Depth
| Last trade - 13.55pm 18/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |